Alkem Laboratories Limited announced that a Wholly Owned Subsidiary ("WOS") of the Company in the name of `Alkem Medtech Private Limited' has been incorporated on 27 March, 2024 in India. Industry to which the entity being acquired Belongs: Pharmaceuticals. Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity): Alkem Medtech has been incorporated for exploring the medical device segment mainly in the cardiovascular and orthopedic fields.

Cost of acquisition and/or the price at which the shares are acquired: Subscription of 2,00,000 Equity Shares of INR 10/- each amounting to INR 20,00,000/-. Percentage of shareholding /control acquired and /or number of shares acquired: 100%. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief): Alkem Medtech is incorporated as a WOS of the Company with the object of exploring the medical device segment mainly in cardiovascular and orthopedic fields.

Date of Incorporation: 27th March, 2024 Country: India.